Agile Therapeutics Inc. (AGRX) Soars 15.97% on March 12

Agile Therapeutics Inc. (AGRX) Soars 15.97% on March 12

Agile Therapeutics Inc. (AGRX) had a good day on the market for Tuesday March 12 as shares jumped 15.97% to close at $1.67. About 2.95 million shares traded hands on 4,215 trades for the day, compared with an average daily volume of n/a shares out of a total float of 43.21 million. After opening the trading day at $1.43, shares of Agile Therapeutics Inc. stayed within a range of $1.68 to $1.32.

With today’s gains, Agile Therapeutics Inc. now has a market cap of $72.17 million. Shares of Agile Therapeutics Inc. have been trading within a range of $3.82 and $0.23 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Agile Therapeutics Inc is a healthcare company dedicated to fulfilling unmet medical needs of today’s women. It offers contraceptive options to women which offer greater convenience and facilitate compliance. The company’s product candidates include Twirla and Progestin. It has also developed a proprietary technology called Skinfusion.

Agile Therapeutics Inc. is based out of Princeton, NJ and has some 13 employees. Its CEO is Alfred Altomari.

Share:
Scroll Up
error: Content is protected !!